vs

Side-by-side financial comparison of Noble Corp plc (NE) and Privia Health Group, Inc. (PRVA). Click either name above to swap in a different company.

Noble Corp plc is the larger business by last-quarter revenue ($764.4M vs $541.2M, roughly 1.4× Privia Health Group, Inc.). Noble Corp plc runs the higher net margin — 11.3% vs 1.7%, a 9.6% gap on every dollar of revenue. On growth, Privia Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs -17.6%). Over the past eight quarters, Privia Health Group, Inc.'s revenue compounded faster (14.2% CAGR vs 9.5%).

Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.

Privia Health Group, Inc. is a U.S.-headquartered healthcare technology and services firm supporting independent practices, health systems, and payers delivering value-based care. It offers population health tools, patient engagement platforms, care coordination support, and workflow solutions to boost patient outcomes and cut operational costs for U.S. healthcare stakeholders.

NE vs PRVA — Head-to-Head

Bigger by revenue
NE
NE
1.4× larger
NE
$764.4M
$541.2M
PRVA
Growing faster (revenue YoY)
PRVA
PRVA
+35.0% gap
PRVA
17.4%
-17.6%
NE
Higher net margin
NE
NE
9.6% more per $
NE
11.3%
1.7%
PRVA
Faster 2-yr revenue CAGR
PRVA
PRVA
Annualised
PRVA
14.2%
9.5%
NE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NE
NE
PRVA
PRVA
Revenue
$764.4M
$541.2M
Net Profit
$86.6M
$9.2M
Gross Margin
Operating Margin
5.6%
2.1%
Net Margin
11.3%
1.7%
Revenue YoY
-17.6%
17.4%
Net Profit YoY
-10.4%
108.0%
EPS (diluted)
$0.54
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NE
NE
PRVA
PRVA
Q4 25
$764.4M
$541.2M
Q3 25
$798.0M
$580.4M
Q2 25
$848.7M
$521.2M
Q1 25
$874.5M
$480.1M
Q4 24
$927.3M
$460.9M
Q3 24
$800.5M
$437.9M
Q2 24
$692.8M
$422.3M
Q1 24
$637.1M
$415.2M
Net Profit
NE
NE
PRVA
PRVA
Q4 25
$86.6M
$9.2M
Q3 25
$-21.1M
$6.9M
Q2 25
$42.9M
$2.7M
Q1 25
$108.3M
$4.2M
Q4 24
$96.6M
$4.4M
Q3 24
$61.2M
$3.5M
Q2 24
$195.0M
$3.5M
Q1 24
$95.5M
$3.0M
Operating Margin
NE
NE
PRVA
PRVA
Q4 25
5.6%
2.1%
Q3 25
6.3%
2.5%
Q2 25
15.9%
0.6%
Q1 25
21.4%
1.1%
Q4 24
18.4%
1.1%
Q3 24
14.4%
1.3%
Q2 24
30.3%
1.2%
Q1 24
16.9%
0.2%
Net Margin
NE
NE
PRVA
PRVA
Q4 25
11.3%
1.7%
Q3 25
-2.6%
1.2%
Q2 25
5.1%
0.5%
Q1 25
12.4%
0.9%
Q4 24
10.4%
1.0%
Q3 24
7.6%
0.8%
Q2 24
28.1%
0.8%
Q1 24
15.0%
0.7%
EPS (diluted)
NE
NE
PRVA
PRVA
Q4 25
$0.54
$0.08
Q3 25
$-0.13
$0.05
Q2 25
$0.27
$0.02
Q1 25
$0.67
$0.03
Q4 24
$0.56
$0.03
Q3 24
$0.40
$0.03
Q2 24
$1.34
$0.03
Q1 24
$0.66
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NE
NE
PRVA
PRVA
Cash + ST InvestmentsLiquidity on hand
$471.4M
$479.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.5B
$737.2M
Total Assets
$7.5B
$1.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NE
NE
PRVA
PRVA
Q4 25
$471.4M
$479.7M
Q3 25
$477.9M
$441.4M
Q2 25
$338.2M
$390.1M
Q1 25
$303.8M
$469.3M
Q4 24
$247.3M
$491.1M
Q3 24
$391.9M
$422.0M
Q2 24
$162.9M
$387.4M
Q1 24
$212.5M
$351.1M
Stockholders' Equity
NE
NE
PRVA
PRVA
Q4 25
$4.5B
$737.2M
Q3 25
$4.5B
$709.1M
Q2 25
$4.6B
$682.9M
Q1 25
$4.7B
$659.4M
Q4 24
$4.7B
$635.2M
Q3 24
$4.7B
$614.9M
Q2 24
$4.0B
$595.4M
Q1 24
$3.9B
$576.8M
Total Assets
NE
NE
PRVA
PRVA
Q4 25
$7.5B
$1.4B
Q3 25
$7.6B
$1.4B
Q2 25
$7.7B
$1.3B
Q1 25
$7.9B
$1.2B
Q4 24
$8.0B
$1.1B
Q3 24
$8.0B
$1.1B
Q2 24
$5.6B
$1.1B
Q1 24
$5.4B
$1.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NE
NE
PRVA
PRVA
Operating Cash FlowLast quarter
$187.1M
$127.5M
Free Cash FlowOCF − Capex
$35.4M
FCF MarginFCF / Revenue
4.6%
Capex IntensityCapex / Revenue
19.9%
Cash ConversionOCF / Net Profit
2.16×
13.93×
TTM Free Cash FlowTrailing 4 quarters
$432.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NE
NE
PRVA
PRVA
Q4 25
$187.1M
$127.5M
Q3 25
$277.1M
$52.0M
Q2 25
$216.4M
$8.0M
Q1 25
$271.1M
$-24.1M
Q4 24
$136.2M
$74.8M
Q3 24
$283.8M
$33.2M
Q2 24
$106.8M
$34.5M
Q1 24
$128.7M
$-33.1M
Free Cash Flow
NE
NE
PRVA
PRVA
Q4 25
$35.4M
Q3 25
$139.5M
Q2 25
$99.8M
Q1 25
$157.5M
Q4 24
$-4.4M
Q3 24
$156.8M
Q2 24
$-34.3M
Q1 24
$-37.9M
FCF Margin
NE
NE
PRVA
PRVA
Q4 25
4.6%
Q3 25
17.5%
Q2 25
11.8%
Q1 25
18.0%
Q4 24
-0.5%
Q3 24
19.6%
Q2 24
-4.9%
Q1 24
-6.0%
Capex Intensity
NE
NE
PRVA
PRVA
Q4 25
19.9%
Q3 25
17.3%
Q2 25
13.7%
Q1 25
13.0%
Q4 24
15.2%
Q3 24
15.9%
Q2 24
20.4%
Q1 24
26.2%
Cash Conversion
NE
NE
PRVA
PRVA
Q4 25
2.16×
13.93×
Q3 25
7.58×
Q2 25
5.05×
2.97×
Q1 25
2.50×
-5.70×
Q4 24
1.41×
17.00×
Q3 24
4.64×
9.38×
Q2 24
0.55×
9.94×
Q1 24
1.35×
-11.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NE
NE

Floaters$559.8M73%
Jackups$145.5M19%
Service Other$59.1M8%

PRVA
PRVA

FFS Patient Care$364.4M67%
Capitated Revenue$71.4M13%
Shared Savings$46.9M9%
FFS Administrative Services$36.0M7%
Care Management Fee PMPM$20.0M4%
Other Revenue$2.5M0%

Related Comparisons